A newly reported randomized clinical trial has renewed interest in psilocybin-assisted research for cocaine use. Here is what Canadians should understand about the findings, limitations, legal status, and safety considerations.
Tag Archives: psilocybin research
Research into psilocybin and depression is moving beyond a simple question of whether a psychedelic experience is necessary. This Canadian guide explains what scientists are investigating, why preparation and support remain important, and what legal and safety considerations matter.
Emerging research is examining whether psilocybin-assisted interventions could help reduce cocaine use. Here is what Canadian readers should understand about the evidence, limitations, safety, and legal context.
Microdosing mushrooms is widely discussed, but online claims often move faster than the evidence. This practical Canadian guide explains what microdosing means, what researchers know, common risks, legal considerations, and how to make more informed decisions.
Psilocybin coverage is growing quickly in Canada, but headlines do not always reflect the strength of the science. This educational guide explains how to evaluate claims, understand legal context, compare cultivar information, and make safer decisions.
Interest in psychedelic therapy is expanding beyond veteran care. Learn why inclusive research, legal awareness, screening, and responsible education matter for Canadians exploring psilocybin and psychedelic medicine.
Canada’s psilocybin landscape is shifting again in 2026. From Ottawa dispensary charges to a growing natural-psilocybin industry, here’s what the latest policy signals actually mean for magic mushroom buyers — and how to shop smartly in an evolving market.
A 2026 Science Daily report found that psilocybin reduced aggressive behavior in fish. While animal models are not human trials, the finding adds to a growing body of research on how psilocybin interacts with emotional regulation. Here’s what Canadian magic mushroom users should take away — and what they shouldn’t.
A wave of 2026 studies is reshaping how researchers think about psilocybin microdosing — from sex-based differences in response to how psilocybin leaves a distinct fingerprint on the brain. Here is what the science actually says, and how Canadian microdosers can apply it to dose, product choice, and safety.